Context Therapeutics Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Context Therapeutics Inc. reported Cash And Cash Equivalents At Carrying Value of $66.00 million for the year ending 2025.

  • Context Therapeutics Inc. showed a decrease of -30.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Context Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Context Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 22,604.5%.
  • Historical annual values: Fiscal year 2025: $66.00 million | Fiscal year 2024: $94.43 million | Fiscal year 2023: $14.45 million | Fiscal year 2022: $35.50 million | Fiscal year 2021: $49.64 million | Fiscal year 2020: $290.7 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: